That is one way to look at it. I personally think it's unlikely. Would Eisai - big pharma with a multi-billion dollar market cap - try and pressure a microcap vendor by threatening to withhold work over $15m over 7 years? Why would they give back anything to Cogstate if this was the case?
This amendment is likely to have been initiated by Cogstate because they think more than $15m can be extracted from the IP by moving Eisai to a non-exclusive agreement.
Eisai always wanted Cognigram as a lead-gen tool for their own approved AZ drugs. Looking at this from afar when a number of AZ treatments are made available, it's much better not to have a digital assessment tied to specific drug company or a specific treatment. There will be less room for conflict of interest and less motivation for big pharma companies to introduce their own individual exclusive digital assessments.
- Forums
- ASX - By Stock
- CGS
- Ann: Eisai and Cogstate Amend Global License Agreement
Ann: Eisai and Cogstate Amend Global License Agreement, page-3
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CGS (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.25 |
Change
0.010(0.81%) |
Mkt cap ! $214.2M |
Open | High | Low | Value | Volume |
$1.27 | $1.27 | $1.24 | $13.81K | 10.94K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5 | $1.23 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.27 | 9527 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 5 | 1.230 |
1 | 2000 | 1.210 |
1 | 860 | 1.160 |
2 | 873 | 1.155 |
2 | 23478 | 1.150 |
Price($) | Vol. | No. |
---|---|---|
1.270 | 9527 | 2 |
1.300 | 1322 | 1 |
1.345 | 4000 | 1 |
1.350 | 2000 | 1 |
1.390 | 10000 | 1 |
Last trade - 16.10pm 27/05/2024 (20 minute delay) ? |
|
|||||
Last
$1.24 |
  |
Change
0.010 ( 1.23 %) |
|||
Open | High | Low | Volume | ||
$1.27 | $1.27 | $1.24 | 1973 | ||
Last updated 15.40pm 27/05/2024 ? |
Featured News
CGS (ASX) Chart |